Literature DB >> 21837954

[Greenlight photoselective vaporization prostatectomy versus thulium laser vaporesection of the prostate for aged high-risk BPH patients with the prostate heavier than 80 g].

Chun-lai Liu1, Dong-wei Xue, Yi-li Liu, Ping Wang.   

Abstract

OBJECTIVE: To compare the effects of greenlight photoselective vaporization prostatectomy (PVP) and thulium laser vaporesection of the prostate (TmLRP) in the treatment of aged high-risk BPH patients with the prostate weighing > 80 g.
METHODS: We included in this study 118 high-risk BPH patients aged 62-96 (mean 76) years with the prostate heavier than 80 g, 82 treated by PVP and the other 36 by TmLRP. Then we compared the operation time, intraoperative bleeding, complications, short-term effectiveness, and surgical cost between the two groups.
RESULTS: All the patients tided over the perioperative period without blood transfusion and serious complications. The mean operation time, postoperative bladder irrigation time and surgical cost were significantly less in the TmLRP than in the PVP group (P < 0.05). Both the procedures remarkably improved the international prostatic symptom score (IPSS), quality of life (QOL), post void residual urine (PVR) and Qmax of the patients (P < 0.05), but with no significant differences between the two groups (P > 0.05).
CONCLUSION: Both PVP and TmLRP are effective and safe for the treatment of aged high-risk BPH patients with the prostate heavier than 80 g, but the latter is superior for its shorter operation time and lower surgical cost.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21837954

Source DB:  PubMed          Journal:  Zhonghua Nan Ke Xue        ISSN: 1009-3591


  6 in total

1.  Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates.

Authors:  Hai-bin Wei; Jian Zhuo; Xiao-wen Sun; Kun Pang; Yi Shao; Sheng-jie Liang; Di Cui; Fu-jun Zhao; Jun-jie Yu; Shu-jie Xia
Journal:  Lasers Med Sci       Date:  2013-09-12       Impact factor: 3.161

2.  The efficacy and safety of 2-μm continuous laser in the treatment of high-risk patients with benign prostatic hyperplasia.

Authors:  Wei Tao; Chuanyang Sun; Boxin Xue; Dongrong Yang; Mingchao Wang; Chunjie Cai; Yuxi Shan
Journal:  Lasers Med Sci       Date:  2016-12-13       Impact factor: 3.161

3.  A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results.

Authors:  Di Cui; Feng Sun; Jian Zhuo; Xiaowen Sun; Bangmin Han; Fujun Zhao; Yifeng Jing; Jun Lu; Shujie Xia
Journal:  World J Urol       Date:  2013-08-03       Impact factor: 4.226

Review 4.  Management of Benign Prostatic Hyperplasia Larger than 100 ml: Simple Open Enucleation Versus Transurethral Laser Prostatectomy.

Authors:  Mohamed A Elkoushy; Mostafa M Elhilali
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

Review 5.  Which laser works best for benign prostatic hyperplasia?

Authors:  Arman Adam Kahokehr; Peter J Gilling
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

6.  Outcome of thulium laser enucleation of prostate surgery in high-risk patients with benign prostatic hyperplasia.

Authors:  Ketan P Vartak; Kshitij Raghuvanshi
Journal:  Urol Ann       Date:  2019 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.